Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Cancers|June 10, 2022
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [177Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot ExperienceFlorian Rosar, Hanna Bader, Mark Bartholomä, et al.
Diagnostics (Basel, Switzerland)|April 26, 2024
Mind the Pitfall: Solitary Nodular Fasciitis Mimicking Extra-Nodal Manifestation of Hodgkin Lymphoma on [18F]FDG PET/CTSuginthan Markandu, Arne Blickle, Caroline Burgard, et al.
Frontiers in Medicine|March 31, 2025
Prediction of lesion-based response to PRRT using baseline somatostatin receptor PETAnas Aouf, Tilman Speicher, Arne Blickle, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
CT-Guided Drainage of Fluid Collections Following Liver Resection: Technical and Clinical Outcome of 143 Patients during a 14-Year PeriodKatharina S Winter, Veronika Greif, Alexander Crispin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 22, 2025
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?Lukas Pillong, Caroline Burgard, Florian Rosar, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Percutaneous CT Fluoroscopy-Guided Core Needle Biopsy of Mediastinal Masses: Technical Outcome and Complications of 155 Procedures during a 10-Year PeriodCaroline Burgard, Robert Stahl, Giovanna Negrao de Figueiredo, et al.
Frontiers in Medicine|February 1, 2024
Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarkerCaroline Burgard, Jakob Engler, Arne Blickle, et al.
Cancers|April 12, 2022
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPCFlorian Rosar, Robert Neher, Caroline Burgard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2023
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registryCaroline Burgard, Connor Hein, Arne Blickle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2024
Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study)Florian Rosar, Joelle Schuler, Caroline Burgard, et al.
Pageof 7